Skip to main content
. 2019 Feb 7;9(3):527–537. doi: 10.1002/2211-5463.12594

Figure 1.

Figure 1

SLC34A2 expression is negatively correlated with the overall survival and event‐free survival of neuroblastoma patients. (A–F) KM‐Plotter analysis showed the correlation between SLC34A2 expression and overall survival (A–C) and relapse‐free survival (D–F) of neuroblastoma patients.